|
|
|
|
| LEADER |
00000nab a2200000ua 4500 |
| 001 |
vtls010829844 |
| 003 |
SK-MaSNL |
| 005 |
20260303145023.0 |
| 008 |
230222s2010 xo |||||||||||||||||eng| |
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-a06g3w
|
| 035 |
|
|
|a urn:nbn:sk:snk-ab5v3x
|
| 035 |
|
|
|a (uuid)34f54d8a-9006-4efa-a62d-027dddff1599
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a eng
|
| 044 |
|
|
|a xo
|c SK
|
| 100 |
1 |
|
|a Paulikova, H.
|4 aut
|9 832862
|
| 245 |
1 |
0 |
|a Synthetic isothiocyanate indole-3-ethyl isothiocyanate (homoITC) enhances sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to cisplatin
|c H. Paulikova, L. Hunakova, P. Stehlik
|
| 700 |
1 |
|
|a Hunakova, L.
|4 aut
|9 1159783
|
| 700 |
1 |
|
|a Stehlik, P.
|4 aut
|9 795861
|
| 773 |
0 |
|
|t Neoplasma : journal of experimental and clinical oncology
|g Roč. 57, č. 5 (2010), s. 473-481
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a EUIPO
|
| 958 |
|
|
|a article5
|
| 999 |
|
|
|c 2000129
|d 2002059
|
